Abstract
The prognosis and treatment of prostatic cancer are strictly related to the status of the draining nodes. Imaging methods commonly employed in the study of the pelvic nodes do not allow exact knowledge of the presence or absence of metastatic deposits and therefore false positive and false negative results are often given. Histological examination of the nodes should be the procedure of choice, but the role of staging pelvic lymphadenectomy in the management of prostatic cancer is still controversial [1, 2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Olsson CA (1985) Staging lymphadenectomy should be an antecedent to treatment in localized prostatic cancer. Urology 25 (Suppl):4–6
Paulson DF (1985) Staging lymphadenectomy should not be an antecedent to treatment in localized prostatic cancer. Urology 25 (Suppl):7–14
Gaeta JF, Asirwathman JE, Miller G, Murphy GP (1980) Histologic grading of primary prostatic cancer: a new approach to an old problem. J Urol 123:689–693
Gaeta JF (1981) Glandular profiles and cellular patterns in prostatic cancer grading. National Prostatic Cancer Project System. Urology 17 (Suppl):33–37
Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50:125–128
Gleason DF, Mellinger GT (1974) Veterans Administration Cooperative Urologic Research Group: prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 111:58–64
Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea and Febiger, Philadelphia, pp 171–197
Brawn PN, Ayala AG, Von Eschenbach AC, Hussey DM, Johnson DE (1982) Histologic grading study of prostate adenocarcinoma: the development of a new system and comparison to other methods. A preliminary study. Cancer 49:525–532
Barzell W, Bean MA, Hilaris BS, Whitmore WF Jr (1977) Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol 118:278–282
Kramer SA, Spahr J, Brendler CB, Glenn JF, Paulson DF (1980) Experience with Gleason’s histopathologic grading in prostatic cancer. J Urol 124:223–225
Paulson DF, Piserchia PV, Gardner W (1980) Predictors of lymphatic spread in prostatic adenocarcinoma: Uro-Oncology Research Group Study. J Urol 123:697–699
Sagalowsky AI, Milam H, Revely LR, Silva FG (1982) Prediction of lymphatic metastases by Gleason histologic grading in prostatic cancer. J Urol 128:951–952
Zincke H, Farrow GM, Myers RP, Benson RC Jr, Furlow WL, Utz DC (1982) Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 128:498–501
Paulson DF (1982) Editorial comment. J Urol 128:501
Parfitt HE Jr, Smith JA Jr, Gliedman JB, Middleton RG (1983) Accuracy of staging A1 carcinoma of the prostate. Cancer 51:2346–2350
Guinan P, Talluri K, Nagubadi S, Sharifi R, Ray V, Shaw M (1983) Evaluation of Gleason classification system in prostate cancer. Urology 21:458–460
Broders AC (1922) Epithelioma of the genito-urinary organs. Ann Surg 75:570–575
Whitmore WF (1973) The natural history of prostatic cancer. Cancer 32:1104–1112
Byar DP (1983) Grading prostate cancer. Urology 22: 562 (letter)
Thomas R, Lewis RW, Sarma DP, Coker GB, Rao MK, Roberts JA (1982) Aid to accurate clinical staging. Histopathologic grading in prostatic cancer. J Urol 128:726–728
Saltzstein SL, McLaughlin AP (1977) Clinico-pathologic features of unsuspected regional node metastases in prostatic adenocarcinoma. Cancer 40:1212–1215
Mostofi FL, Price EB Jr (1973) Tumors of the male genital system. In: Atlas of tumor pathology. Second Series, Fascicle 8. Armed Forces Institute of Pathology, Washington DC, 218–223
Myers RP, Neves RJ, Farrow GM, Utz DC (1982) Nuclear grading of prostatic adenocarcinoma: light microscopic correlation with disease progression. Prostate 3:423–432
Epstein JJ, Berry SJ, Eggleston JC (1984) Nuclear roundness factor: a predictor of progression in untreated stage A2 prostate cancer. Cancer 54:666–671
ten Kate FJW, Gallee MPW, Schmitz PIM, Joebsis AC, van der Heul RO, Prins MEF, Blom JHM (1986) Problems in grading of prostatic carcinoma: interobserver reproducibility of five different grading systems. World J Urol 4:147–152
Rousselet MC, Saint-André JP, Six P, Soret JY (1986) Reproducibilité et valeur pronostique des grades histologiques de Gleason et de Gaeta dans les carcinomes de la prostate. Ann Urol 20:317–332
Wajsman Z (1981) Lymph node evolution in prostatic cancer. Is pelvic lymph node dissection necessary? Urology 17 (Suppl):80–82
Piscioli F, Leonardi E, Reich A, Luciani L (1984) Percutaneous lymph node aspiration biopsy and tumor grade in staging of prostatic carcinoma. Prostate 5:459–468
Luciani L, Scappini P, Pusiol T, Piscioli F (1985) Comparative study of lymphography and aspiration cytology in the staging of prostatic carcinoma. Urol Int 40:181–189
Piscioli F, Scappini P, Luciani L (1985) Aspiration cytology in the staging of urologic cancer. Cancer 56:1173–1180
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Luciani, L., Scappini, P., Failoni, G.L., Piscioli, F. (1988). Combined Lymph Node Aspiration Cytology and Tumour Grade in Staging of Prostatic Cancer. In: Luciani, L., Piscioli, F. (eds) Aspiration Cytology in the Staging of Urological Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-1452-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1452-9_22
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1454-3
Online ISBN: 978-1-4471-1452-9
eBook Packages: Springer Book Archive